Saxenda liraglutide injection, solution, DailyMed (2025) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) First generic GLP-1 indicated for weight loss, Teva Pharmaceuticals Investor Relations (2025) Liraglutide injection, solution, DailyMed (2025) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, Food and Drug Administration (2024) Bioequivalence and interchangeability of generic medications, Merck Manual Consumer Version (2025) Liraglutide injection, DailyMed (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) FDA drug shortages, Food and Drug Administration (2025) Compounding when drugs are on FDAs Drug Shortages List, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Your best path to managing the GLP-1 cost without insurance assistance will be the self-pay programs above if your plan denies coverage or imposes restrictions
stand out for scalable production and competitive pricing, while Ningbo Keysing Biotechnology Co., Ltd
Patients should avoid injecting into areas with scarring, bruising, inflammation, or skin conditions
Similarly, Zhang et al.'s research also indicated that genetically predisposed GLP-1Ras were correlated with decreased risks of AF, cardiac arrest, and ventricular fibrillation (124)